Bobby Khan, MD, PhD, is Assistant Professor of Medicine/Cardiology at Emory University
Bobby V. Khan, MD, PhD, Chairman of the Board of the SCA Foundation, has been named a Fulbright Scholar. The Fulbright Program is the flagship international educational exchange program sponsored by the U.S. government and is designed to “increase mutual understanding between the people of the United States and the people of other countries.”
In his role as a Fulbright Scholar, Dr. Khan will serve as a Visiting Professor at the University of Prince Edward Island in Canada, during the 2009-2010 school year. His research and teaching will address global health and preventive forms of medicine, specifically those related to cardiovascular health. The program will start in September 2009, and his Fulbright lecture will be given at the university in the spring of 2010.
Khan is Assistant Professor of Medicine/Cardiology at Emory University School of Medicine and Director of the Coronary Care Unit and Cardiovascular Research at Grady Memorial Hospital in Atlanta. He serves as an attending physician at Grady, providing bedside and didactic teaching on a daily basis. In addition, he teaches medical students and graduate students and supervises PhD and post-doctoral fellows. He holds visiting professorships at multiple universities.
Dr. Khan’s research interests include studying mechanisms of action in the progression of atherosclerosis and heart failure and drug/non-drug therapies that may slow or stall this progression. He has a particular interest in studying ways to reduce the risk of sudden cardiac arrest in African-Americans, a medically underserved population.
A popular international lecturer, Dr. Khan’s work has been published in numerous peer-review journals. In addition, he is a manuscript reviewer for Atherosclerosis, Hypertension, Circulation, Diabetes Care, the Journal of the American College of Cardiology, the American Journal of Cardiology and Biochemica et Biophysica Acta. He has served as an abstract reviewer for the American College of Cardiology (ACC) and the American Heart Association and as an ACC Sessions chair for five years. He serves as a consultant to several pharmaceutical companies and holds multiple patents.
For more information, click here.